Evidence map›Paper›PMID 40066033›Full record

ArticleHeliyon2025

T and NK cell functionality in a patient harboring heterozygous novel BCL11B p.Asp632fsAla∗91 and STX11 p.R129P mutations.

Lorenzo Erra, Ana Colado, Franco Gino Brunello, Emma Prieto, Verónica Goris, Mariana Villa, Matías Oleastro, Marcelo Martí, Roberto Gabriel Pozner, Mercedes Borge and 1 more

Abstract read
In one paragraph

Article in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lorenzo ErraIQUIBICEN - Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Argentina.
Ana ColadoInstituto de Medicina Experimental (IMEX), CONICET/Academia Nacional de Medicina, Buenos Aires, Argentina.
Franco Gino BrunelloIQUIBICEN - Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Argentina.
Emma PrietoHospital Nacional de Pediatría J. P. Garrahan, Buenos Aires, Argentina.
Verónica GorisHospital Nacional de Pediatría J. P. Garrahan, Buenos Aires, Argentina.
Mariana VillaHospital Nacional de Pediatría J. P. Garrahan, Buenos Aires, Argentina.
Matías OleastroHospital Nacional de Pediatría J. P. Garrahan, Buenos Aires, Argentina.
Marcelo MartíIQUIBICEN - Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Argentina.
Roberto Gabriel PoznerInstituto de Medicina Experimental (IMEX), CONICET/Academia Nacional de Medicina, Buenos Aires, Argentina.
Mercedes BorgeInstituto de Medicina Experimental (IMEX), CONICET/Academia Nacional de Medicina, Buenos Aires, Argentina.
María Belén AlmejunIQUIBICEN - Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Argentina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BCL11B is a transcription factor essential for central nervous system development and T-cell differentiation that regulates numerous genes across various pathways. Heterozygous BCL11B defects can lead to a broad spectrum of phenotypes, including neurological disorders with or without immunological features. STX11 encodes a t-SNARE protein crucial for the final fusion of lytic granules with the plasma membrane of NK-cells and CD8

Indexed as

AutoimmunityBCL11BSTX11

Identifiers

PMID40066033
PMCPMC11891720

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.